AbbVie's longstanding alliance with Hungarian drugmaker Gedeon Richter has already given it one blockbuster medicine – Vraylar for schizophrenia and bipolar disorder – and the two partners ...

Gedeon Richter's drug is the only licensed GnRH antagonist option and, unlike GnRH agonists like Takeda's Prostap ...

Endometriosis affects millions of people - and this new breakthrough treatment could be a game-changer for some ...

Nice initially rejected the drug, but new evidence was provided by the manufacturer Gedeon Richter to address questions about effectiveness and value for money. The drug will only be made available on ...

NICE estimates that 1,000 women could benefit from Ryeqo, which can be taken once-daily up until the menopause.

The new drug, called relugolix-estradiol-norethisterone, is a combination pill that blocks specific hormones that contribute to endometriosis, while also providing necessary hormone replacement ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...